Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
-
Miller Lite Unveils New Creative Platform, "Legendary Moments Start with a Lite," Starring Christopher Walken
-
Concord Appoints Chris Baker as Executive Chairman
-
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
-
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
-
Aurora Mobile Congratulates Zhipu on Successful Hong Kong Listing
-
Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target
-
Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program
-
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
-
Woof Gang Achieves Record Growth in 2025
-
Anika Therapeutics Announces Leadership Transition
-
ONAR Completes Sale of Certain Legacy Assets in a Secured $1.5 Million Seller-Financed Transaction
-
Transpire Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
-
Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones
-
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
-
Troilus Delivers on Key Development Milestones in 2025 and Enters a Pivotal Transition Year in 2026
-
Kinross to provide update on Round Mountain Phase X, Kettle River-Curlew and Bald Mountain Redbird 2 projects
-
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
-
AAVantgarde to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference
-
Fixing of coupon rates – Nykredit Realkredit A/S
-
Net Asset Value(s)
-
Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to Advance DARKFOX T-cell Engager into First-in-Human Studies
-
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
-
Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study
-
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
-
BitMEX Report Finds Crypto Perpetuals Enter Post-Yield Era
-
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform
-
Inventus Secures $2.1 Million Gold Pre-Payment and Provides Exploration Update
-
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
-
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy
-
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
-
Bridgehead Earns ISO/IEC 27001:2022 Certification, Strengthening Global Information Security Standards
-
Clough Global Opportunities Fund Declares Monthly Distributions For Q1 2026, Increasing Its Distribution By 7.2% To $0.0537 Per Share; Announces Market Update Conference Call
-
Clough Global Equity Fund Declares Monthly Distributions for Q1 2026, Increasing its Distribution by 12.2% to $0.0729 Per Share; Announces Market Update Conference Call
-
Clough Global Dividend and Income Fund Declares Monthly Distributions for Q1 2026, Increasing Its Distribution by 7.6% to $0.0566 Per Share; Announces Market Update Conference Call
-
Fury Reviews 2025 Achievements and Outlines 2026 Exploration Priorities
-
IntelyCare Acquires CareRev to Create Comprehensive Workforce Staffing Platform for Health Systems
-
Lleida.net Begins 2026 With a 55.62% Increase in Clients Driven by Regulatory Demand
-
First Foundation Inc. Announces Fourth Quarter 2025 Earnings Release Details
-
Mantle Vault Hits $100M Milestone, Cementing Bybit as Premier Gateway for On-Chain Yield
-
The Buckle, Inc. Reports December 2025 Net Sales
-
Endeavour Silver Produces 6,486,661 Oz Silver and 37,164 Oz Gold, for a total of 11.2 Million Silver Equivalent Oz in 2025
-
RentRedi Recognized for Premier Customer Service by National Association of Realtors®
-
DAVE STEWART FORMS RARE ENTITY TO CREATE BREAKTHROUGH IP AND BUILD VENTURES THAT MOVE CULTURE INTO NEW TERRITORY
-
Miami International Holdings Reports Trading Results for December and Full-Year 2025
-
Helen of Troy Limited Reports Third Quarter Fiscal 2026 Results
-
RPM Reports Fiscal 2026 Second-Quarter Results
-
TELUS engages TD Securities and Jefferies as financial advisors to support TELUS Health partnership and monetisation strategy
